Sign In
Buy VERX
$12.91
+0.310 (+2.46%)
At Close: Jul 31, 2026
Vertex (VERX) Q4 Earnings Match Estimates
09:35am, Wednesday, 11'th Feb 2026
Vertex (VERX) came out with quarterly earnings of $0.17 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.15 per share a year ago.
Vertex Announces Fourth Quarter and Full Year 2025 Financial Results
07:05am, Wednesday, 11'th Feb 2026
KING OF PRUSSIA, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial
Vertex Gears Up to Report Q4 Earnings: Is a Beat in the Cards?
11:45am, Tuesday, 10'th Feb 2026
VRTX is set to report Q4 results amid strong Trikafta demand. Alyftrek launches are gaining traction while investors are eyeing Casgevy and Journavx sales.
Should You Buy Vertex Before Feb. 12?
09:35am, Tuesday, 10'th Feb 2026
Vertex saw its shares drop after its third-quarter earnings report in November. The biotech is looking to expand its portfolio into pain management and renal therapies.
Should You Buy Vertex Pharmaceuticals Before Feb. 12?
01:46pm, Monday, 09'th Feb 2026
Vertex's core franchise probably won't lead to any surprises, but newer launches could. The company should see significant pipeline progress this year.
Vertex Q4 Earnings Preview: What To Expect This Week
11:30am, Monday, 09'th Feb 2026
Vertex Pharmaceuticals is downgraded to Hold ahead of Q4 earnings due to underwhelming growth from key new drugs. Journavx and Casgevy sales remain niche, raising doubts about their ability to drive t
Vertex, Inc. $VERX Shares Bought by Principal Financial Group Inc.
04:30am, Sunday, 08'th Feb 2026
Principal Financial Group Inc. increased its holdings in Vertex, Inc. (NASDAQ: VERX) by 44.6% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 892,949 sha
Vertex (VERX) Expected to Announce Earnings on Wednesday
04:42am, Wednesday, 04'th Feb 2026
Vertex (NASDAQ: VERX - Get Free Report) is projected to issue its Q4 2025 results before the market opens on Wednesday, February 11th. Analysts expect the company to announce earnings of $0.17 per sha
Pre-Market Stock Futures: Futures are trading higher after a strong bounce-back Monday, with all major indices ending the day higher, as we started February on a winning note. Investors were able to l
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
10:08pm, Monday, 02'nd Feb 2026
SHANGHAI, Feb. 2, 2026 /PRNewswire/ -- WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has signed a license
Final Trades: Vertex Pharma, Kimberly-Clark, S&P Global and Exxon Mobil
01:19pm, Thursday, 22'nd Jan 2026
The Investment Committee give you their top stocks to watch for the second half.
Critical Survey: Pcs Edventures!.Com (OTCMKTS:PCSV) and Vertex (NASDAQ:VERX)
01:15am, Thursday, 22'nd Jan 2026
Vertex (NASDAQ: VERX - Get Free Report) and Pcs Edventures!.Com (OTCMKTS:PCSV - Get Free Report) are both computer and technology companies, but which is the better investment? We will compare the two
Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th
04:00pm, Tuesday, 20'th Jan 2026
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, after the financial mark
Vertex, Inc. (NASDAQ:VERX) Short Interest Update
02:27am, Tuesday, 20'th Jan 2026
Vertex, Inc. (NASDAQ: VERX - Get Free Report) was the recipient of a large increase in short interest during the month of December. As of December 31st, there was short interest totaling 7,266,393 sha
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings
05:00pm, Sunday, 11'th Jan 2026
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor meetings in January, including the company's schedul
